ConductScience.org, home

Gene784

CACNB3: calcium voltage-gated channel auxiliary subunit beta 3

Cite this record

ConductScience Library. CACNB3: calcium voltage-gated channel auxiliary subunit beta 3. Genes, record 784. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/784

FollowSave as evidenceDownload JSON
Drug
PREGABALIN515 trials
Disease
alcohol dependence125 drugs
Sources
13 sources
Release
gene-search-2026-11-13-0.2.1

Gene

Symbol
CACNB3
HGNC
Name
calcium voltage-gated channel auxiliary subunit beta 3
HGNC
NCBI Gene ID
784
NCBI Gene
HGNC ID
HGNC:1403
HGNC
Ensembl
ENSG00000167535
NCBI Gene
Aliases
CAB3, CACNLB3
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P54284Voltage-dependent L-type calcium channel subunit beta-348416Ensembl, GeneID, HGNC

Source UniProt

Download CSV of proteins

Patents104

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
US 20260337666 A12026-10-2925568P54284Espacenet
US 20260193644 A12026-07-093614P54284Espacenet
US 12577609 B22026-03-1725568P54284Espacenet
JP 2026004568 A2026-01-1439601P54284Espacenet
EP 4641201 A22025-10-293614P54284Espacenet
JP 2025517969 A2025-06-123614P54284Espacenet
JP 2025062604 A2025-04-1410678P54284Espacenet
US 20250084141 A12025-03-131508P54284Espacenet
JP 2025032204 A2025-03-1125568P54284Espacenet
US 12227549 B22025-02-181508P54284Espacenet

See all 104 patentsDownload CSV of patents

Drugs11

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
ATAGABALINCHEMBL593430Voltage-gated calcium channel modulatorMODULATORChEMBL
BEPRIDILCHEMBL1008Voltage-gated calcium channel blockerBLOCKERChEMBL
BEPRIDIL HYDROCHLORIDECHEMBL1200382Voltage-gated calcium channel blockerBLOCKERChEMBL
GABAPENTINCHEMBL940Voltage-gated calcium channel modulatorMODULATORChEMBL
GABAPENTIN ENACARBILCHEMBL1628502Voltage-gated calcium channel modulatorMODULATORChEMBL
IMAGABALINCHEMBL2103836Voltage-gated calcium channel modulatorMODULATORChEMBL
PHLOROGLUCINOLCHEMBL473159Voltage-gated calcium channel blockerBLOCKERChEMBL
PREGABALINCHEMBL1059Voltage-gated calcium channel modulatorMODULATORChEMBL
SULOCTIDILCHEMBL404849Voltage-gated calcium channel blockerBLOCKERChEMBL
TERODILINECHEMBL363295Voltage-gated calcium channel blockerBLOCKERChEMBL

See all 11 drugsDownload CSV of drugs

Trials370

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

NIH grants363

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCACNB3 papersNewest fiscal year
P30EY016665Core Grant for Vision Research22025
R01AI042347Host-pathogen interactions in experimental cholera22025
T32AI007520Molecular Microbiology Training Grant22025
DP1DA054394Building Bridges to Allow Cross-species Translational genetics for the Study of Addiction12025
K01DK129404Unraveling the role of osteocytes in metabolic dysfunction associated with obesity12025
P01AG026276Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study12025
P01CA163227Androgen Receptor Action in Castration Resistant Prostate Cancer12025
P30AG066444Alzheimer's Disease Research Center12025
P30AG066509University of Washington Alzheimer's Disease Research Center12025
P30AR073752Washington University Rheumatic Diseases Research Resource-based Center12025

Source NIH's project files

See all 363 nih grantsDownload CSV of nih grants

Papers307

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
CACNB3 defects are associated with infantile idiopathic nystagmus.Brain Commun202641822111PubTator, text miningPubMed
The ER membrane protein complex acts as a chaperone to promote the biogenesis of multi-bundle membrane proteins.bioRxiv202641648177PubTator, text miningPubMed
Establishing synthetic ribbon-type active zones in a heterologous expression system.Elife202641528127PubTator, text miningPubMed
Proteomic Analysis Infers Optimized ATP-Production in Guard Cell Mitochondria.Physiol Plant202540999960PubTator, text miningPubMed
Development of machine learning models for diagnostic biomarker identification and immune cell infiltration analysis in PCOS.J Ovarian Res202539754246PubTator, text miningPubMed
Cavβ3 Contributes to the Maintenance of the Blood-Brain Barrier and Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis.Arterioscler Thromb Vasc Biol202438957986PubTator, text miningPubMed
Utilizing genetics and proteomics to assess the role of antihypertensive drugs in human longevity and the underlying pathways: a Mendelian randomization study.Eur Heart J Cardiovasc Pharmacother202438769606PubTator, text miningPubMed
Genetic and immune determinants of E. coli liver abscess formation.Proc Natl Acad Sci U S A202338096412PubTator, text miningPubMed
Stroma-associated FSTL3 is a factor of calcium channel-derived tumor fibrosis.Sci Rep202338044354PubTator, text miningPubMed
A characteristic cerebellar biosignature for bipolar disorder, identified with fully automatic machine learning.IBRO Neurosci Rep202338025660PubTator, text miningPubMed

See all 307 papersDownload CSV of papers

Sources 13

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
  • USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
  • USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/784

GET https://conductscience.org/api/genes/v1/784/patents?page=2